MARINDA BENJAMIN: Open Payments
NPI 1356777171 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 59 payments from 19 companies in 2025. Trend: 2023 $1,323 · 2024 $1,745 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $418 |
| AstraZeneca Pharmaceuticals LP | 3 | $254 |
| Novo Nordisk Inc | 9 | $166 |
| PFIZER INC. | 5 | $99 |
| Astellas Pharma US Inc | 4 | $88 |
| Corcept Therapeutics | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Eisai Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: VRAYLAR, UBRELVY, FARXIGA, AIRSUPRA, Veozah, QULIPTA, NURTEC ODT, Korlym.
Industry payments across OH — which companies pay providers there.
